LYFE Sciences · Project HERA
Variant Interpretation · Classification Report
Variant classification summary
NM_006005.3:c.1675G>A
WFS1
· NP_005996.2:p.(Ala559Thr)
· NM_006005.3
GRCh37: chr4:6303197 G>A
·
GRCh38: chr4:6301470 G>A
Gene:
WFS1
Transcript:
NM_006005.3
Final call
VUS
Variant details
Gene
WFS1
Transcript
NM_006005.3
Protein
NP_005996.2:p.(Ala559Thr)
gnomAD AF
0.00485437495194609 (v4.1)
ClinVar
Likely benign
OncoKB
Classification rationale
Interpretation summary
Generated evidence synthesis
1
No patient-specific parental testing, de novo observation, affected-relative segregation, or affected-relative non-segregation evidence was supplied; all four criteria remain not assessed.
2
No VCEP covers WFS1 in this case; generic ACMG/AMP 2015 definitions govern.
3
PS4 could not be numerically assessed because verified case-control counts or an OR/RR with a confidence interval were unavailable.
4
PP5 and BP6 were not met because the exact ClinVar record has no expert-panel classification; its benign/likely benign laboratory assertions are insufficient for these restricted rules.
Final determination:
Generic ACMG/AMP 2015 fallback rules do not meet any pathogenic, likely pathogenic, benign, or likely benign combination threshold because no criterion is applied, so the final call is VUS.
Criteria assessment
ACMG/AMP criteria review
Criteria shown when status is available
All criteria require review: For research and educational purposes only.
| Criterion | Status | Rationale | Evidence used |
|---|---|---|---|
| PVS1 | N/A | Not applicable: PVS1 requires a null variant (nonsense, frameshift, canonical splice, start-loss or stop-loss), and this is a missense variant. |
pvs1_generic_framework
generic_acmg_combination_rules
|
| PS1 | Not assessed | Not assessed: A559T was reported but not established as pathogenic, and the exact ClinVar record contains benign or likely benign submissions. |
clinvar
PMID:12565131
|
| PS2 | Not assessed | Not assessed: no documented patient-specific de novo observation confirms both maternity and paternity for NM_006005.3:c.1675G>A. |
|
| PS3 | Not assessed | Not assessed: no variant-specific well-established functional study provides a damaging-effect result for WFS1 p.Ala559Thr. |
|
| PS4 | Not assessed | Not assessed: no verified affected-versus-control counts, odds ratio, or confidence interval were available for c.1675G>A, so the PS4 >5.0 and CI-excluding-1.0 requirements cannot be evaluated. |
|
| PM1 | Not assessed | Not assessed: Cancer Hotspots returned no WFS1 A559 result, while no authoritative WFS1 critical-domain list is available for residue 559. |
hotspots
|
| PM2 | Not met | Not met: gnomAD v4.1 AF is 0.00485437, substantially above the <=0.0001 PM2 supporting threshold, with 20 homozygotes observed. |
gnomad_v2
gnomad_v4
|
| PM3 | Not assessed | Not assessed: no affected-proband observation documents c.1675G>A in trans with a pathogenic WFS1 variant or establishes phase by parental or offspring testing. |
clinvar
|
| PM4 | N/A | Not applicable: PM4 requires a protein-length change, and this is a missense variant. |
pvs1_generic_framework
generic_acmg_combination_rules
|
| PM5 | Not assessed | Not assessed: no pathogenic alternate missense at Ala559 is established, and the PM5 candidate collection contains zero same-residue candidates. |
pm5_candidates
PMID:12565131
|
| PM6 | Not assessed | Not assessed: no patient-specific observation documents NM_006005.3:c.1675G>A as assumed de novo without parental confirmation. |
|
| PP1 | Not assessed | Not assessed: 0 affected family-member transmissions or informative meioses are documented for NM_006005.3:c.1675G>A. |
|
| PP2 | Not assessed | Not assessed: the required WFS1 gene-level evidence for low benign missense variation and a common missense disease mechanism is unavailable. |
|
| PP3 | Not met | Not met: REVEL 0.407 is below the PP3 supporting threshold of 0.644. |
revel
|
| PP4 | Not assessed | Not assessed: the supplied evidence lacks a patient phenotype or family-history description demonstrating high specificity for a single-genetic-etiology disease. |
|
| PP5 | Not met | Not met: ClinVar has zero expert-panel submissions and reports benign/likely benign assertions, not an expert-panel pathogenic or likely-pathogenic classification. |
clinvar
|
| BA1 | Not met | Not met: gnomAD v4.1 grpmax FAF is 0.0055781, below the 0.05 BA1 threshold, in a population with 1,180,036 observed alleles. |
gnomad_v2
gnomad_v4
|
| BS1 | Not met | Not met: default gnomAD v4.1 grpmax FAF is 0.0055781, below the generic BS1 threshold of 0.01 despite adequate population size. |
gnomad_v2
gnomad_v4
|
| BS2 | Not assessed | Not assessed: gnomAD v4.1 reports 20 homozygotes, but no record establishes that any was a healthy adult with expected early full penetrance. |
gnomad_v2
gnomad_v4
|
| BS3 | Not assessed | Not assessed: no variant-specific well-established functional study shows that WFS1 p.Ala559Thr has no damaging effect. |
|
| BS4 | Not assessed | Not assessed: 0 tested affected relatives are documented as lacking NM_006005.3:c.1675G>A, so non-segregation cannot be established. |
|
| BP1 | Not assessed | Not assessed: the available evidence does not establish that WFS1 disease is caused primarily by truncating variants. |
|
| BP2 | Not assessed | Not assessed: no individual-level observation establishes c.1675G>A in cis or trans with a pathogenic WFS1 variant, and no phase result is documented. |
clinvar
|
| BP3 | N/A | Not applicable: BP3 requires an in-frame indel in a repeat region, and this is a missense variant. |
pvs1_generic_framework
generic_acmg_combination_rules
|
| BP4 | Not met | Not met: REVEL 0.407 exceeds the BP4 supporting threshold of <=0.29. |
revel
|
| BP5 | Not assessed | Not assessed: no case-level alternate molecular diagnosis or pathogenic alternative explanation was supplied for a carrier of c.1675G>A. |
|
| BP6 | Not met | Not met: ClinVar's benign/likely benign record has zero expert-panel submissions, so non-expert laboratory assertions cannot trigger BP6. |
clinvar
|
| BP7 | N/A | Not applicable: BP7 requires a synonymous variant, and this is a missense variant. |
generic_acmg_combination_rules
|
Disclaimer:
The content and results provided by LYFE Sciences are for research and educational purposes only and must not be used as a substitute for professional medical judgment, diagnosis, or treatment. Always consult a qualified healthcare professional before making any clinical decisions.